What is the expected value of the licensing arrangement to LAB? Assume a 5% royalty fee on any cash flows that Merck received from Davanrik after a successful launch. Note that these 5% royalty fees have already been deducted from the commercialization present values used in Task 1.

Article: https://drive.google.com/file/d/1jvjWdwRzEAJkRhUmGDHK-ISLz-W2WWhY/view?usp=sharing Questions: https://drive.google.com/file/d/1eS0SlE280_-pnhO_9FNFebiO5h8AFnot/view?usp=sharing